Well… company is basically worthless.
gone from having phase 2 trials running to 2 very early pre-clinical assets.
assume Mautner will resign and have to take responsibility for the failed strategy. I hope GK will find a buyer for his shares at whatever price these fall to and also sell out so the company can clean slate.
I plan to just hold and check in few years from now.
Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $15.23K | 145.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7857 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |